Study identifier:D8450R00006
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
multicenter observational retrospective-prospective study of prevalence and clinical characteristics of transthyretin amyloidosis cardiomyopathy in Russian patients with heart failure with preserved ejection fraction in real clinical practice
Transthyretin amyloidosis cardiomyopathy, heart failure with preserved ejection fraction
N/A
No
-
All
6000
Observational
18 Years - n/a
Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Mar 2024 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|